Daniel Sessler News Today

Study finds that continuous monitoring of vital signs (respiratory rate, oxygen saturation and pulse rate) with Portrait Mobile results in alarm data which may be used to optimize system configuration and mitigate alarm fatigue in the ward environment.Study results revealed at the American Society of Anesthesiologis...

GE HealthCare today announced new data from a pilot study conducted with Cleveland Clinic evaluating the Portrait Mobile wireless and wearable monitoring solution. The results demonstrate that continuous patient monitoring with Portrait Mobile...

Study finds that continuous monitoring of vital signs with Portrait Mobile results in alarm data which may be used to optimize system configuration and mitigate alarm fatigue in the ward...

GE Healthcare has achieved a significant milestone with the clearance of its revolutionary medical innovation - the Portrait Mobile wireless and wearable monitoring solution, approved by the United States Food and Drug Administration (FDA). Designed to play a pivotal role in post-intensive care patient recovery, this cutting-edge device empowers healthcare professionals with real-time continuous monitoring of vital signs, enhancing patient care and safety.

The smartphone-sized device offers continuous monitoring of respiration rate while allowing patient mobility.

GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs, using wearable sensors with a wireless protocol, to... -Today at 08:07 am- MarketScreener

GE HealthCare (Nasdaq: GEHC) received FDA 510(k) clearance for its Portrait Mobile wireless and wearable monitoring solution.

GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs, using wearable sensors with a wireless protocol, to help catch inpatient deterioration early.Portrait Mobile introduces an innovative measurement technology to continuously...

PROTECT trial finds targeting body temperatures a few degrees higher is unnecessary

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.